Purpose
Advance knowledge of recent clinical evidence pertaining to von Willebrand Disease (VWD)
Target Audience
Meets the educational needs of physicians involved in the care of patients with VWD
Program Overview
Recent clinical evidence has provided new possibilities in the diagnosis and treatment of patients with VWD. This activity has been designed to explore recent diagnostic issues, including:
- Role of screening tests
- Importance of severe type 1 versus type 3 diagnosis
- Collagen binding assay in the diagnosis of type 2
- Diagnosis of type 2N
- Genetic analysis
It will also explore current treatment issues, including:
- FVIII/VWF concentrates and criteria for potency
- Importance of normal multimer pattern for FVIII/VWF concentrates
- Risk of venous thrombosis with high FVIII levels
- Recombinant VWF concentrates
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Review the recent clinical evidence applicable to the VWD patient population
- Describe recent diagnostic issues, including new options
- Explain current treatment options
Credit Designation
The Postgraduate Institute for Medicine (PIM) designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of
PIM and ProMed Institute. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Faculty Disclosure Statement
All faculty participating in continuing education activities sponsored by
PIM are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.
|
|
Original airdates: June 13 and
June 21, 2005
Expiration date: June 2008
Note: This program no longer offers credits
but is still available for review.
Estimated time to complete activity: 1 hour
Login or register to access this activity.
Agenda
5 minutes—Welcome and Introduction
20 minutes—Diagnostic Issues
20 minutes—Treatment Issues
10 minutes—Questions and Answers
5 minutes—Closing Remarks
|
|
If your institution is interested in coordinating a Lunch-N-Learn to access this archive, contact ProMed Institute at 1-800-229-9590.
E-MAIL THIS PAGE TO A FRIEND
|
|
